ニューヨークにおける片頭痛の臨床試験
ニューヨーク内の拠点で、片頭痛に関する15件の研究が参加者を募集しています。
ニューヨーク内の都市
公式研究テキスト（英語）
Study of EVO756 in Adults With Migraine
- Clinosis - Dent Neurologic Instite, Amherst
被験者募集中第2相
18歳〜64歳 · 全性別 · 2026/10/02更新 · NCT07616128A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- True North Neurology, Port Jefferson Station
被験者募集中第1相
6歳〜11歳 · 全性別 · 2026/09/28更新 · NCT06995729Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Montefiore Medical Center, The Bronx
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/28更新 · NCT05156398MMA Embolization for Refractory Chronic Migraine
- University of Buffalo Medical Center, Buffalo
- Mount Sinai, New York
- Stony Brook University Medical Center, Stony Brook
被験者募集中
18歳〜65歳 · 全性別 · 2026/09/25更新 · NCT06735833A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache
- Maimonides Medical Center, Brooklyn
被験者募集中第4相
18歳〜65歳 · 全性別 · 2026/09/24更新 · NCT06473597Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Dent Neurosciences Research Center, Amherst
- True North Neurology, Commack
- New York Neurology Associates, New York
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Dent Neurosciences Research Center, Amherst
- True North Neurology, Commack
- Northwell Health IRB, Great Neck
- 他4件
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Dent Neurologic Institute - Amherst /ID# 270260, Amherst
被験者募集中第3相
12歳〜17歳 · 全性別 · 2026/09/22更新 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- Dent Neurological Institute, Amherst
被験者募集中
10歳〜17歳 · 全性別 · 2026/09/21更新 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Nuvance Health Institute, Kingston
- Northwell Health, Manhasset
- Mt Sinai Icahn School of Medicine, New York
被験者募集中第4相
18歳〜70歳 · 全性別 · 2026/09/16更新 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Dent Neurologic Institute - Amherst /ID# 231182, Amherst
- SUNY Upstate Medical University /ID# 239898, Syracuse
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/14更新 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Dent Neuro Institute, Buffalo, Amherst
- SPRI Clinical Trials, LLC, Brooklyn
- True North Neurology, Commack
- 他4件
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/20更新 · NCT07645924A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- True North Neurology, Commack
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/06/12更新 · NCT05164172Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines
- Neuroscience Institute at Great Neck, Great Neck
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/05/22更新 · NCT07061847RELAXaHEAD for Headache Patients (Phase III)
- NYU Langone Health, New York
被験者募集中
16歳〜80歳 · 全性別 · 2025/10/10更新 · NCT06077838ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。